As a consequence, a HR of 2.736 indicated that the risk score could significantly contribute to the prediction of survival of glioma patients, eliminating the influence of other factors such as sex, age, grade, radiotherapy, chemotherapy and the molecular status (IDHDampR, TP53.1, EGFR, ATRX and EZH2) (Table 3). The gene discussed is EZH2; the disease is glioma.